Want to see CH:MEDX full AI Analyst Report?
medmix AG (MEDX) Stock Statistics & Valuation Metrics
Total Valuation
medmix AG has a market cap or net worth of CHF 453.89M. The enterprise value is CHF 610.90M.
- Market Cap
- CHF 453.89M
- Enterprise Value
- CHF 610.90M
Share Statistics
medmix AG has 41,262,370 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 41,262,370
- Owned by Insiders
- ―
- Owned by Institutions
- 6.00%
Financial Efficiency
medmix AG’s return on equity (ROE) is 0.02 and return on invested capital (ROIC) is 2.61%.
- Return on Equity (ROE)
- 0.02
- Return on Assets (ROA)
- 0.01
- Return on Invested Capital (ROIC)
- 2.61%
- Return on Capital Employed (ROCE)
- 0.03
- Revenue Per Employee
- 173.17K
- Profits Per Employee
- 2,473.908
- Employee Count
- 2,587
- Asset Turnover
- 0.46
- Inventory Turnover
- 3.76
Valuation Ratios
The current PE Ratio of medmix AG is 4384.00. medmix AG’s PEG ratio is -46.10.
- PE Ratio
- 4384.00
- PS Ratio
- 1.02
- PB Ratio
- 1.05
- Price to FCF
- 14.07
- Price to Operating Cash Flow
- 7.52
- PEG Ratio
- -46.10
Income Statement
In the last 12 months, medmix AG had revenue of 448.00M and earned 6.40M in profits. Earnings per share was 0.16.
- Revenue
- 448.00M
- Gross Profit
- 161.90M
- Operating Income
- 27.40M
- Pretax Income
- 9.00M
- Net Income
- 6.40M
- EBITDA
- 79.70M
- Earnings Per Share (EPS)
- 0.16
Cash Flow
In the last 12 months, operating cash flow was 59.30M and capital expenditures -27.60M, giving a free cash flow of 31.70M billion.
- Operating Cash Flow
- 59.30M
- Free Cash Flow
- 31.70M
- Free Cash Flow per Share
- 0.78
Dividends & Yields
medmix AG pays an annual dividend of CHF 0.10, resulting in a dividend yield of 0.91%
- Dividend Per Share
- CHF 0.10
- Dividend Yield
- 0.91%
- Payout Ratio
- 15.38%
- Free Cash Flow Yield
- 7.11%
- Earnings Yield
- 0.02%
Stock Price Statistics
- Beta
- 0.95
- 52-Week Price Change
- 21.78%
- 50-Day Moving Average
- 9.56
- 200-Day Moving Average
- 9.18
- Relative Strength Index (RSI)
- 73.97
- Average Volume (3m)
- 67.66K
Important Dates
medmix AG upcoming earnings date is Feb 23, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Jul 23, 2026
- Next Earnings Date
- Feb 23, 2027
- Ex-Dividend Date
- Apr 20, 2026
Financial Position
medmix AG as a current ratio of 1.54, with Debt / Equity ratio of 77.59%
- Current Ratio
- 1.54
- Quick Ratio
- 1.10
- Debt to Market Cap
- 0.56
- Net Debt to EBITDA
- 2.82
- Interest Coverage Ratio
- 3.04
Taxes
In the past 12 months, medmix AG has paid 2.00M in taxes.
- Income Tax
- 2.00M
- Effective Tax Rate
- 0.22
Enterprise Valuation
medmix AG EV to EBITDA ratio is 8.45, with an EV/FCF ratio of 20.91.
- EV to Sales
- 1.52
- EV to EBITDA
- 8.45
- EV to Free Cash Flow
- 20.91
- EV to Operating Cash Flow
- 11.18
Balance Sheet
medmix AG has CHF 111.30M in cash and marketable securities with CHF 319.40M in debt, giving a net cash position of -CHF 208.10M billion.
- Cash & Marketable Securities
- CHF 111.30M
- Total Debt
- CHF 319.40M
- Net Cash
- -CHF 208.10M
- Net Cash Per Share
- -CHF 5.04
- Tangible Book Value Per Share
- CHF 1.69
Margins
Gross margin is 36.73%, with operating margin of 6.27%, and net profit margin of 0.02%.
- Gross Margin
- 36.73%
- Operating Margin
- 6.27%
- Pretax Margin
- 0.32%
- Net Profit Margin
- 0.02%
- EBITDA Margin
- 17.94%
- EBIT Margin
- 6.27%
Analyst Forecast
The average price target for medmix AG is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -6.64%
- EPS Growth Forecast
- ―
Scores
- Smart Score
- ―
- AI Score
- 53
